News

US DEA Defends Withholding Tinubu-Linked Drug Records, Cites Protection of Confidential Sources

US DEA Defends Withholding Tinubu-Linked Drug Records, Cites Protection of Confidential Sources

The United States Drug Enforcement Administration (DEA) has formally defended its decision to withhold portions of investigative records linked to a historical criminal investigation involving Nigerian President Bola Ahmed Tinubu, citing the critical need to protect confidential sources and sensitive law enforcement techniques.

The agency’s stance was detailed in a September 23, 2026, filing before the United States District Court for the District of Columbia. The submission responds to a Freedom of Information Act (FOIA) lawsuit initiated by plaintiff Aaron Greenspan, which seeks records related to a federal investigation into an alleged international drug-trafficking and money-laundering organization active between 1988 and 1994. Court records from the ongoing litigation have previously identified Tinubu among the individuals referenced in the scope of the request.

In its latest submission, the US government pushed back against the plaintiff’s challenge to the DEA’s “Vaughn Index,” a legal document detailing the justification for withholding specific records. The government argued that the repetitive nature of the justifications was entirely natural, given that the withheld materials consisted of similar formal investigative documents, such as DEA-6, DEA-292, and DEA-210 reports.

A central pillar of the DEA’s defense revolves around the absolute protection of informants. Quoting the agency’s “Davis Declaration,” the filing asserted that any disclosure of such material “could reasonably be expected to disclose the identity of a confidential source.” The declaration emphasized that information on confidential sources “has long been afforded the most comprehensive protection of all the FOIA exemptions,” concluding that the risk of exposing these individuals far outweighed “the relatively insignificant public interest in the disclosure of the information.”

SEE ALSO: FBI Tells US Court Secret Files Linked To President Bola Tinubu Cover Many Subjects And Criminal Cases

Furthermore, the government invoked FOIA Exemption 7(E) to shield non-public details regarding the specific investigative techniques employed during the historical drug operation. While the plaintiff conceded that law enforcement could withhold such technical details, they sought to compel the release of a redacted, sealed declaration. The government maintained that revealing these methods would compromise the integrity of past and potentially future law enforcement operations.

This procedural filing builds upon an April 2025 ruling by U.S. District Judge Beryl Howell, who previously rejected the agencies’ attempt to issue a “Glomar response,” a legal maneuver where an agency refuses to confirm or deny the existence of records. Judge Howell noted that the investigation’s existence had already been officially acknowledged, thus forcing the agencies to justify their specific redactions.

However, it is crucial to note that the September 23 filing is strictly procedural. It does not disclose the substantive contents of the DEA records, nor does it confirm whether any confidential sources made allegations against Tinubu, what specific transactions were identified, or if the DEA ever found evidence of criminal wrongdoing.

As the FOIA litigation continues, the legal maneuvering highlights a classic transparency dilemma. While the DEA’s refusal to release the documents is firmly grounded in established legal exemptions designed to protect intelligence gathering, the persistent redactions ensure that the full historical narrative of this decades-old investigation remains locked behind the heavy doors of national security protocol.

Filed under: News